FDA — authorised 23 December 1999
- Application: NDA020845
- Marketing authorisation holder: MALLINCKRODT IRELAND
- Local brand name: INOMAX
- Indication: GAS — INHALATION
- Status: approved
🇺🇸 Nitric oxide by inhalation INOMAX in United States
FDA authorised Nitric oxide by inhalation INOMAX on 23 December 1999
Marketing authorisation
Nitric oxide by inhalation INOMAX in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Nitric oxide by inhalation INOMAX approved in United States?
Yes. FDA authorised it on 23 December 1999.
Who is the marketing authorisation holder for Nitric oxide by inhalation INOMAX in United States?
MALLINCKRODT IRELAND holds the US marketing authorisation.